Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cancer Therapeutics-Related Cardiac Dysfunction　- Insights From Bench and Bedside of Onco-Cardiology.

Circulation journal : official journal of the Japanese Circulation Society - 25 Aug 2020

Kadowaki Hiroshi, Akazawa Hiroshi, Ishida Junichi, Komuro Issei

Abstract excerpt

Improvements in the long-term survival of cancer patients have led to growing awareness of the clinical importance of cancer therapeutics-related cardiac dysfunction (CTRCD), which can have a considerable effect on the prognosis and quality of life of cancer patients and survivors. Under such circumstances, onco-cardiology/cardio-oncology has emerged as a new discipline, with the aim of best managing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Cardiotoxicity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cardiovascular Diseases

Share to Comorbidity

Share to Neoplasms

Share to Quality of Life

Share to Risk Factors

Source

Identifiers

PMID: 32727978
DOI: 10.1253/circj.CJ-20-0467

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cancer Therapeutics-Related Cardiac Dysfunction - Insights From Bench and Bedside of Onco-Cardiology.PMID 32727978Read ↗

Common genetic predisposition for heart failure and cancer.Semantic proximity Read ↗

Cancer therapy–induced cardiac metabolic reprogramming: A new frontier in cardio-oncologySemantic proximity Read ↗

Heart Failure in Relation to Anthracyclines and Other Chemotherapies.Semantic proximity Read ↗

Epigenetic Changes Associated With Anthracycline‐Induced CardiotoxicitySemantic proximity Read ↗

Emerging mitochondrial signaling mechanisms in cardio-oncology: beyond oxidative stressSemantic proximity Read ↗

Deciphering the roles of cellular and extracellular non-coding RNAs in chemotherapy-induced cardiotoxicitySemantic proximity Read ↗

Mitochondria and Doxorubicin-Induced Cardiomyopathy: A Complex InterplaySemantic proximity Read ↗

Meta-analysis of genome-wide association studies for cancer therapy-related cardiovascular dysfunction and functional mapping highlight an intergenic region close to TP63.Semantic proximity Read ↗

Heart disease mortality in cancer survivors: A population-based study in JapanSemantic proximity Read ↗

Anthracycline-mediated cardiomyopathy: Basic molecular knowledge for the cardiologistSemantic proximity Read ↗

The association between early‐onset cardiac events caused by neoadjuvant or adjuvant chemotherapy in triple‐negative breast cancer patients and some novel autophagy‐related polymorphisms in their genomic DNA: a real‐world studySemantic proximity Read ↗

Genetic Background in Patients with Cancer Therapy-Induced CardiomyopathySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.